Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
Titel:
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
Auteur:
Pinto, Carmine Zucali, Paolo Andrea Pagano, Maria Grosso, Federica Pasello, Giulia Garassino, Marina Chiara Tiseo, Marcello Soto Parra, Hector Grossi, Francesco Cappuzzo, Federico de Marinis, Filippo Pedrazzoli, Paolo Bonomi, Maria Gianoncelli, Letizia Perrino, Matteo Santoro, Armando Zanelli, Francesca Bonelli, Candida Maconi, Antonio Frega, Stefano Gervasi, Erika Boni, Luca Ceresoli, Giovanni Luca